The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Upper tract urothelial carcinoma transcriptome profiling and immune microenvironment characterization.
 
Wesley Yip
No Relationships to Disclose
 
Kwanghee Kim
No Relationships to Disclose
 
Fengshen Kuo
No Relationships to Disclose
 
Andrew Thomas Lenis
No Relationships to Disclose
 
Jie-Fu Chen
No Relationships to Disclose
 
Wenhuo Hu
No Relationships to Disclose
 
Timothy Nguyen Clinton
No Relationships to Disclose
 
Carissa Ellen Chu
No Relationships to Disclose
 
Nima Almassi
No Relationships to Disclose
 
Andrew Tracey
No Relationships to Disclose
 
Peter Reisz
No Relationships to Disclose
 
Jasmine Thomas
No Relationships to Disclose
 
Lucas Nogueira
Consulting or Advisory Role - Bayer
Speakers' Bureau - Astellas Pharma; Bayer
 
Yoichi Fujii
No Relationships to Disclose
 
Gopa Iyer
Consulting or Advisory Role - Basilea; Bayer; Flare Therapeutics; Janssen; Loxo/Lilly; Mirati Therapeutics
Speakers' Bureau - Gilead Sciences; Lynx Group
Research Funding - Bayer (Inst); Debiopharm Group (Inst); Janssen (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Seagen (Inst)
 
Hikmat A. Al-Ahmadie
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; EMD Serono; Janssen Biotech; PAIGE.AI
 
A. Ari Hakimi
No Relationships to Disclose
 
Taha Merghoub
Stock and Other Ownership Interests - Imvaq therapeutics
Honoraria - Leap Therapeutics; Pfizer
Consulting or Advisory Role - ImmunoGenesis; Immunos Therapeutics
Research Funding - Bristol-Myers Squibb; Surface Oncology
Patents, Royalties, Other Intellectual Property - inventor on patent applications related to work on oncolytic viral therapy, alphavirus-based vaccines, neo-antigen modeling, CD40, GITR, OX40, PD-1 and CTLA-4.
 
David B. Solit
Stock and Other Ownership Interests - Fore Biotherapeutics; Loxo; Scorpion Therapeutics; Vividion Therapeutics
Consulting or Advisory Role - BridgeBio Pharma; Lilly; Pfizer; QED Therapeutics; Scorpion Therapeutics; Syros Pharmaceuticals; Vividion Therapeutics
 
Jonathan Coleman
Travel, Accommodations, Expenses - Digital Angiography Reading Center (I)
Other Relationship - Steba Biotech